Astronics Corp. 10-Q Summary: Q1 2025
Business Context and Reporting Period
Astronics Corporation (ATRO) is a provider of advanced technologies to the global aerospace, defense, and electronics industries. The company operates through two segments: Aerospace (commercial transport, military, general aviation) and Test Systems (government/defense, mass transit). This report covers the quarterly period ended March 29, 2025.
Key Financial Metrics
| Metric | Q1 2025 | Q1 2024 |
|---|---|---|
| Sales | $205.9 million | $185.1 million |
| Gross Profit | $60.8 million | $47.5 million |
| Gross Margin | 29.5% | 25.7% |
| Operating Income | $13.1 million | $1.7 million |
| Net Income | $9.5 million | $(3.2) million |
| Diluted EPS | $0.26 | $(0.09) |
| Operating Cash Flow | $20.6 million | $2.0 million |
| Cash & Restricted Cash | $25.9 million | $6.6 million |
| Long-term Debt | $160.1 million | $168.7 million |
| Backlog | $673.0 million | $605.6 million |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated sales increased 11.3% year-over-year, driven by a 17.0% increase in the Aerospace segment ($191.4M vs $163.6M). This offset a 32.0% decline in the Test Systems segment ($14.6M vs $21.4M).
- Profitability Improvement: The company returned to profitability with $9.5M net income compared to a $3.2M loss in Q1 2024. Operating margin improved to 6.4% from 0.9%.
- Legal Reserve Impact: SG&A expenses increased by $4.1M, primarily due to a $6.2M adjustment to legal reserves regarding a UK patent infringement dispute (Lufthansa). This included a $0.5M increase to the damage award and $5.7M in accrued interest.
- Interest Expense Reduction: Net interest expense decreased 45% to $3.2M from $5.8M, following the refinancing of credit facilities and the issuance of Convertible Senior Notes in late 2024.
- Accounting Presentation: Research and Development (R&D) expenses were reclassified from Cost of Products Sold to a separate line item below Gross Profit. All periods were revised to reflect this change.
Guidance, Outlook, and Risks
- Outlook: Management expects cash flow from operations to fund operations and the upcoming payment of the Lufthansa damage award ($12.4M) and interest ($5.7M) in Q2 2025. Book-to-bill ratio for the quarter was 1.36:1.
- Legal Contingencies:
- UK (Lufthansa): A liability of $18.1M is recorded for damages and interest. A hearing on May 16, 2025, will address appeals and legal fee reimbursement (estimated at $7.2M by Lufthansa, not yet reserved).
- Germany: A reserve of $17.2M exists for indirect claims and interest, classified as non-current.
- France: No liability recorded as loss exposure is not currently probable or estimable.
- Risks: Key risks include supply chain pressures, labor availability, potential tariffs impacting costs, and the cyclical nature of aerospace build rates. The company is monitoring production challenges at Boeing and the Russia-Ukraine conflict.
- Liquidity: The company has a $220M ABL Revolving Credit Facility with $187.1M available (net of reserves and letters of credit). It remains in compliance with all financial covenants.
Investor Verification Checklist
- Legal Payment Timing: Verify the execution of the $18.1M payment (damages + interest) to Lufthansa in Q2 2025 and monitor the outcome of the May 16, 2025 hearing regarding legal fee reimbursement.
- Test Systems Recovery: Assess the impact of the $1.9M revenue reduction from the mass transit contract revision and the timeline for the project's completion (now expected in 2026).
- Convertible Notes: Monitor the fair value of the $165M Convertible Senior Notes (trading at approx. $228.4M) and potential dilution if the stock price exceeds 130% of the conversion price ($22.89).
- Customer Concentration: Note that Safran Group accounted for 10.3% of sales in Q1 2025; monitor for any concentration risks.
- Working Capital: Review the significant increase in operating cash flow ($20.6M) to ensure sustainability amidst potential tariff-induced cost increases.